Bausch Health (BHC)
(Delayed Data from NYSE)
$6.83 USD
+0.05 (0.74%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $6.83 0.00 (0.00%) 5:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BHC 6.83 +0.05(0.74%)
Will BHC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BHC
Bausch (BHC) Up 21.4% Since Last Earnings Report: Can It Continue?
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
BHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say
Bausch Health (BHC) Lags Q2 Earnings Estimates
Why Is Bausch (BHC) Down 13% Since Last Earnings Report?
Other News for BHC
Is BHC signaling selling opportunity? Fell Below 50 Day Moving Average shows up after plummeting 5.57%
Bollinger Band Squeeze appears for BHC after 1.1% move
Interesting BHC Put And Call Options For January 2028
Is BHC primed for upward momentum? Pocket Pivot shows up after advancing 0.14%
NR7 appears for BHC after 1.4% move